Search Results - "le Roux, Carel W"

Refine Results
  1. 1
  2. 2

    A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management by Pi-Sunyer, Xavier, Astrup, Arne, Fujioka, Ken, Greenway, Frank, Halpern, Alfredo, Krempf, Michel, Lau, David C.W, le Roux, Carel W, Violante Ortiz, Rafael, Jensen, Christine Bjørn, Wilding, John P.H

    Published in The New England journal of medicine (02-07-2015)
    “…This trial compared once-daily liraglutide, a glucagon-like peptide-1 analogue, with placebo in overweight or obese patients. Liraglutide was associated with…”
    Get full text
    Journal Article
  3. 3

    The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor - An Update by Jakubowska, Agnieszka, Roux, Carel W le, Viljoen, Adie

    Published in Endocrinology and metabolism (Seoul) (01-02-2024)
    “…Obesity is the fifth leading risk factor for global deaths with numbers continuing to increase worldwide. In the last 20 years, the emergence of…”
    Get full text
    Journal Article
  4. 4

    Weight Loss, Satiety, and the Postprandial Gut Hormone Response After Esophagectomy: A Prospective Study by Elliott, Jessie A, Docherty, Neil G, Eckhardt, Hans-Georg, Doyle, Suzanne L, Guinan, Emer M, Ravi, Narayanasamy, Reynolds, John V, Roux, Carel W le

    Published in Annals of surgery (01-07-2017)
    “…OBJECTIVE:To prospectively characterize changes in body weight, satiety, and postprandial gut hormone profiles following esophagectomy. BACKGROUND:With…”
    Get full text
    Journal Article
  5. 5

    Amylin as a Future Obesity Treatment by Dehestani, Babak, Stratford, Nicholas Rs, le Roux, Carel W

    Published in Journal of Obesity & Metabolic Syndrome (01-12-2021)
    “…Obesity is defined as abnormal or excessive fat accumulation that contributes to detrimental health impacts. One-third of the population suffers from obesity,…”
    Get full text
    Journal Article
  6. 6

    Weight loss to disrupt type 2 diabetes by Alsaqaaby, Moath S., le Roux, Carel W.

    Published in Diabetology international (01-07-2023)
    “…Obesity is now recognised as a disease associated with significant morbidity and mortality. One of the most common metabolic complications of obesity is type 2…”
    Get full text
    Journal Article
  7. 7

    Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters by LE ROUX, Carel W, AYLWIN, Simon J. B, BATTERHAM, Rachel L, BORG, Cynthia M, COYLE, Frances, PRASAD, Vyas, SHUREY, Sandra, GHATEI, Mohammad A, PATEL, Ameet G, BLOOM, Stephen R

    Published in Annals of surgery (2006)
    “…To study the effect of bariatric surgery on the entero-hypothalamic endocrine axis of humans and rodents. Bariatric surgery is the most effective obesity…”
    Get full text
    Journal Article
  8. 8

    Increased postprandial energy expenditure may explain superior long term weight loss after Roux-en-Y gastric bypass compared to vertical banded gastroplasty by Werling, Malin, Olbers, Torsten, Fändriks, Lars, Bueter, Marco, Lönroth, Hans, Stenlöf, Kaj, le Roux, Carel W

    Published in PloS one (03-04-2013)
    “…Gastric bypass results in greater weight loss than Vertical banded gastroplasty (VBG), but the underlying mechanisms remain unclear. In addition to effects on…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Roux-en-Y Gastric Bypass Surgery Increases Respiratory Quotient and Energy Expenditure during Food Intake by Werling, Malin, Fändriks, Lars, Olbers, Torsten, Bueter, Marco, Sjöström, Lars, Lönroth, Hans, Wallenius, Ville, Stenlöf, Kaj, le Roux, Carel W

    Published in PloS one (22-06-2015)
    “…The mechanisms determining long-term weight maintenance after Roux-en-Y gastric bypass (RYGB) remain unclear. Cross sectional studies have suggested that…”
    Get full text
    Journal Article
  12. 12

    Bariatric surgery for the treatment of chronic kidney disease in obesity and type 2 diabetes mellitus by Docherty, Neil G., le Roux, Carel W.

    Published in Nature reviews. Nephrology (01-12-2020)
    “…Bariatric surgery is an effective therapy for obesity, hypertension and type 2 diabetes mellitus that is refractory to maximal medical therapy. Results of…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Mechanisms of Weight Loss After Obesity Surgery by Akalestou, Elina, Miras, Alexander D, Rutter, Guy A, le Roux, Carel W

    Published in Endocrine reviews (01-02-2022)
    “…Obesity surgery remains the most effective treatment for obesity and its complications. Weight loss was initially attributed to decreased energy absorption…”
    Get full text
    Journal Article
  15. 15

    Do Gut Hormones Contribute to Weight Loss and Glycaemic Outcomes after Bariatric Surgery? by Papamargaritis, Dimitris, le Roux, Carel W

    Published in Nutrients (26-02-2021)
    “…Bariatric surgery is an effective intervention for management of obesity through treating dysregulated appetite and achieving long-term weight loss…”
    Get full text
    Journal Article
  16. 16

    Review of multimodal treatment for type 2 diabetes: combining metabolic surgery and pharmacotherapy by Sudlow, Alexis, le Roux, Carel W, Pournaras, Dimitri J

    “…Treating type 2 diabetes mellitus (T2DM) in patients with obesity remains a challenge for physicians, endocrinologists and surgeons, a fact supported by…”
    Get full text
    Book Review Journal Article
  17. 17

    Mechanisms underlying weight loss after bariatric surgery by Miras, Alexander D., le Roux, Carel W.

    “…Bariatric surgery is an effective treatment for obesity, providing long-term maintenance of weight loss. Here, the authors discuss the various mechanisms by…”
    Get full text
    Journal Article
  18. 18

    Changes in gut hormone profile and glucose homeostasis after laparoscopic sleeve gastrectomy by Papamargaritis, Dimitris, M.D, le Roux, Carel W., M.D., Ph.D., F.R.C.Path, Sioka, Eleni, M.D, Koukoulis, George, M.D., Ph.D, Tzovaras, George, M.D., Ph.D, Zacharoulis, Dimitris, M.D., Ph.D

    Published in Surgery for obesity and related diseases (01-03-2013)
    “…Abstract Background Changes in glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) levels after bariatric surgery have been proposed as a mechanism for…”
    Get full text
    Journal Article
  19. 19

    COVID-19 alters thinking and management in metabolic diseases by le Roux, Carel W.

    Published in Nature reviews. Endocrinology (01-02-2021)
    “…Metabolic diseases emerged as important risk factors for severe COVID-19, but the mechanisms responsible remained unclear for some time. The severity of…”
    Get full text
    Journal Article
  20. 20

    Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes by Riddle, Matthew C, Cefalu, William T, Evans, Philip H, Gerstein, Hertzel C, Nauck, Michael A, Oh, William K, Rothberg, Amy E, le Roux, Carel W, Rubino, Francesco, Schauer, Philip, Taylor, Roy, Twenefour, Douglas

    Published in Diabetes care (30-08-2021)
    “…Improvement of glucose levels into the normal range can occur in some people living with diabetes, either spontaneously or after medical interventions, and in…”
    Get full text
    Journal Article